دورية أكاديمية

Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial

التفاصيل البيبلوغرافية
العنوان: Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial
المؤلفون: Motzer, Robert J., Robbins, Paul B., Powles, Thomas, Albiges, Laurence, Haanen, John B., Larkin, James, Mu, Xinmeng Jasmine, Ching, Keith A., Uemura, Motohide, Pal, Sumanta K., Alekseev, Boris, Gravis, Gwenaelle, Campbell, Matthew T., Penkov, Konstantin, Lee, Jae Lyun, Hariharan, Subramanian, Wang, Xiao, Zhang, Weidong, Wang, Jing, Chudnovsky, Aleksander, di Pietro, Alessandra, Donahue, Amber C., Choueiri, Toni K.
المساهمون: Pfizer, Merck KGaA
المصدر: Nature Medicine ; volume 26, issue 11, page 1733-1741 ; ISSN 1078-8956 1546-170X
بيانات النشر: Springer Science and Business Media LLC
سنة النشر: 2020
مصطلحات موضوعية: General Biochemistry, Genetics and Molecular Biology, General Medicine
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1038/s41591-020-1044-8
الإتاحة: https://doi.org/10.1038/s41591-020-1044-8Test
https://www.nature.com/articles/s41591-020-1044-8.pdfTest
https://www.nature.com/articles/s41591-020-1044-8Test
حقوق: https://www.springer.com/tdmTest ; https://www.springer.com/tdmTest
رقم الانضمام: edsbas.37ACAA12
قاعدة البيانات: BASE